August 19, 2026 — RNews

#immunogenicity — Wednesday, August 19, 2026 (1 items)

hot top new

← prev day next day →

2

Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled study. (linkinghub.elsevier.com)

Sawe F … Phalipon A Lancet Infectious Diseases 2026-08-19

#vaccination #immunogenicity #shigella #conjugate #pediatric